Reyedar

Reyedar is a Medtech startup established in 2020 that innovatively blends eye tracking and artificial intelligence to create diagnostic tools that are fast, objective, and patient-friendly. Focused on addressing the challenges posed by visual impairments and neurodegenerative disorders like Glaucoma, Parkinson's Disease, and Multiple Sclerosis, Reyedar provides an alternative to traditional screenings, which are often invasive or unreliable, particularly for young children and the elderly.

Leveraging high-speed oculography and machine learning, Reyedar translates eye movement data into actionable medical insights, fostering early detection of neurological conditions. Their technology significantly reduces the time required for assessments from hours to just five minutes, using advanced signal processing techniques and deep recurrent neural networks.

Headquartered in The Netherlands, the company recently secured a €3.00M Seed Round on 05 July 2023, with investments from Cottonwood Technology Fund, UNETI Ventures, NV NOM, Blue Sparrows MedTech Funds, and Pupil Labs, indicating strong industry confidence and potential for growth in the Health Care, Manufacturing, and Medical Devices sectors.